BPC-157 (Body Protection Compound-157) is a pentadecapeptide consisting of 15 amino acids. It is a partial sequence of a protein found in human gastric juice. The peptide has been the subject of extensive preclinical research.
In preclinical studies, BPC-157 has been investigated for a wide range of potential biological activities. The most extensively studied area is tissue repair, including tendons, ligaments, muscles, bones, and the gastrointestinal tract.
The proposed mechanisms of action include upregulation of growth factor expression (particularly VEGF), modulation of the nitric oxide system, and interaction with the dopaminergic system. Some studies suggest it may promote angiogenesis at injury sites.
BPC-157 has also been studied for its effects on the gastrointestinal tract, which is relevant given its gastric origin. Preclinical research has examined its potential role in inflammatory bowel conditions and gastric ulcers.
It is important to note that BPC-157 has not been approved for human use by any regulatory agency. All references are based on preclinical studies. This peptide is sold exclusively for laboratory research purposes.
Disclaimer: This article is for educational purposes only. All peptides are sold for laboratory research use only. Not for human consumption.